The Ensign Group, Inc. (ENSG) Stock Price & How to Invest
Last updated November 2026
Short answer
ENSG is The Ensign Group, a fast-growing post-acute healthcare operator that runs skilled nursing and senior living facilities through a decentralized network of local subsidiaries. It is one of the few consistent double-digit compounders in an otherwise tough industry, so investors treat it as a serial-acquirer growth story that trades at a premium to peers. As of November 20, 2026 the stock trades near $178, roughly 26 times trailing earnings, after a flat year for the share price despite ~15% revenue growth and a fifth straight quarterly EPS beat in Q3.
ENSG stock price
As of 2026-11-20, The Ensign Group, Inc. (ENSG) last closed at $176.32, down 4.7% over the past year. Over the past 52 weeks it has traded between $147.13 and $215.83.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or The Ensign Group, Inc.'s investor relations page. Walnut is informational, not investment advice.
ENSG key stats
At $176.32 on November 20, 2026, The Ensign Group, Inc. (ENSG) has a market cap of $10.3B, a P/E of 26.2 on trailing earnings (20.1 on forward earnings) and a dividend yield of 0.15%.
- Market cap
- $10.3B
- P/E (trailing)
- 26.2
- P/E (forward)
- 20.1
- EPS (trailing 12 months)
- $6.72
- Price to book
- 4.0
- Dividend yield
- 0.15%
- Beta
- 0.65
Market cap, P/E and yield are measured at the $176.32 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with The Ensign Group, Inc. (ENSG)?
The last two weeks for The Ensign Group, Inc., as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- ENSG closed at $176.32 on November 20, 2026, down 6.4% over the past five trading days (from $188.41).
The Ensign Group, Inc. filed no current, quarterly or annual report with the SEC in the last two weeks.
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
The Ensign Group, Inc. (ENSG) latest quarter
The Ensign Group reported revenue of $1.5 billion for Q3 2026, up 14% from a year earlier (The Ensign Group, Oct 27, 2026).
Source: The Ensign Group Q3 2026 results, Oct 27, 2026. Full earnings breakdown
What does The Ensign Group, Inc. (ENSG) do?
The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). As of mid-2026 its subsidiaries operated roughly 398 healthcare operations, including about 48 senior living communities, across 17 states, with a real estate portfolio of roughly 183 properties; in the third quarter it added 22 more operations, including its first in Florida. The business model is to acquire underperforming but strategically located facilities and turn them into profitable local operations, generating revenue mostly from Medicare, Medicaid, and private-insurance reimbursement for short-term rehab and long-term care.
The investment picture centers on durable, acquisition-fueled growth. Ensign has delivered years of double-digit revenue and earnings gains by improving occupancy, skilled mix, and staff retention at newly acquired sites while keeping a strong balance sheet. Revenue rose about 18% in Q1 2026 to roughly $1.39 billion and about 17% in Q2 to roughly $1.44 billion. Q3 2026, reported October 27, grew about 14.5% to roughly $1.48 billion, a little below the ~$1.51 billion expected beforehand, while adjusted EPS of $2.03 beat the ~$1.97 consensus, the fifth straight quarterly beat. Adjusted EBITDA was about $191 million and operating margin rose to roughly 9.3% from 7.4% a year earlier. Management nudged full-year revenue guidance to about $5.91 billion at the midpoint, and analysts now expect 2026 EPS near $7.98, rising to roughly $8.77 in 2027 on ~$6.66 billion of revenue. RBC raised its target to $239 and UBS to $240 after the report. The share price has not kept pace: it jumped to about $188 after the release, then slipped back to $177.93 on November 20, 2026, up only ~2% year to date, down ~1% over one year, and well below its 52-week high of $218. That leaves the trailing P/E near 26x and the forward P/E near 20x. Management called the new Florida and Texas operations very challenged, so they will take time to contribute. The trade-off is a premium valuation and heavy dependence on government reimbursement rates and labor costs, which makes execution and policy the key variables, since an aging population supplies a long structural tailwind for demand.
What's driving The Ensign Group, Inc. (ENSG)?
1. Serial-acquisition growth engine
Ensign's core strategy is buying underperforming skilled nursing and senior living facilities and improving their operations. In 2026 it kept adding operations, including a multi-facility Texas expansion for roughly $342 million and 22 new operations in the third quarter that brought it into Florida for the first time, from what management calls a deep, seller-friendly pipeline. This repeatable playbook is the main driver of its long record of double-digit revenue growth, though management described the Florida and Texas additions as very challenged buildings that will need time.
2. Occupancy and skilled-mix gains
Same-facility and transitioning occupancy reached record levels near 84 to 85 percent in early 2026, while a richer skilled mix (more Medicare and managed-care days) lifted margins. Improving director-of-nursing retention and lower staff turnover reduced reliance on expensive agency labor, directly supporting profitability.
3. Real estate value via Standard Bearer
Ensign owns a large and growing portfolio of the underlying real estate through its captive REIT subsidiary, giving it control over roughly 183 properties. Owning the buildings adds a rental income stream, provides financing flexibility for deals, and represents embedded asset value beyond the operating business.
4. Aging-population demand tailwind
Long-term demographics favor post-acute care as the US population ages and demand for skilled nursing and senior living rises. This structural tailwind supports occupancy and gives Ensign a long runway of facilities to acquire and turn around across its 17-state footprint.
What are the risks to The Ensign Group, Inc. (ENSG)?
Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. The skilled nursing industry is labor-intensive and exposed to persistent workforce shortages and wage inflation, and proposed federal minimum-staffing mandates could raise costs if reinstated. Growth depends on continuously finding and integrating acquisitions at attractive prices, so a slower pipeline or integration missteps would slow the compounding; the new Florida market brings a busy litigation environment, by management's own account, and revenue growth eased to about 14.5% in Q3 from 17-18% earlier in the year. The stock also trades at a premium valuation, which leaves less cushion if growth decelerates. Finally, the sector carries regulatory, litigation, and quality-of-care compliance risk that can produce fines or reputational damage. The stock's flat performance over the past year, despite steady beats, shows how much of the growth was already in the price at the start of 2026.
What is the The Ensign Group, Inc. (ENSG) forecast?
5 analysts publish price targets on ENSG, averaging $225.80 as of November 2026, or +28.1% against the $176.32 share price on November 20, 2026. The published targets run from $210.00 to $240.00, a narrow spread, and the ratings split 4 buy, 1 hold, 0 sell. Over the last six months there have been 6 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.
Read the full ENSG forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.
Is ENSG a buy or a sell?
We give no verdict on The Ensign Group, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. Serial-acquisition growth engine. Ensign's core strategy is buying underperforming skilled nursing and senior living facilities and improving their operations. The most optimistic published target, $240.00, assumes this works close to its best case.
The case against. Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. The most pessimistic target, $210.00, is roughly what ENSG is worth if this bites instead.
Read the full bull and bear case on ENSG, including what would have to change to break either one. Walnut is not an investment adviser.
Has The Ensign Group, Inc. (ENSG) split its stock?
Yes. The Ensign Group, Inc. (ENSG) has had one share split in the last 10 years:
- 1069:1000 on October 1, 2019, so every share held became 1.069 shares.
A split changes the share count and the price per share and leaves the value of a holding unchanged. Someone holding $1,000 of ENSG the day before the 1069:1000 split held $1,000 the day after, in more shares at a proportionally lower price. Historical prices from before the date are normally shown split-adjusted, which is why a long-run chart shows no cliff.
Splits matter mainly because they make older price figures confusing to compare by hand, and because a board choosing to split is usually signalling that the price has run up far enough to feel awkward for smaller buyers. Neither is a reason to buy or sell.
How is The Ensign Group, Inc. (ENSG) valued?
Market cap, P/E and dividend yield at today's price are in the ENSG key stats above. The business figures below come from The Ensign Group, Inc.'s reported results as of November 2026 and change when it next reports.
- Revenue (TTM): ~$5.67B
- Revenue growth (Q3 2026, yoy): ~+14.5%
- Q3 2026 adjusted EPS: $2.03 vs ~$1.97 est.
- Net income (TTM): ~$399M (~7.0% margin)
- 2026 consensus EPS: ~$7.98 on ~$5.91B revenue
As of November 2026: Ensign trades at a premium to typical healthcare-facility peers on the strength of its consistent double-digit growth; at ~$178 on November 20, 2026 the stock sits about 18% below its 52-week high even though Q3 2026 revenue grew ~14.5% and adjusted EPS beat estimates again. Yahoo's total-debt figure of roughly $2.29 billion includes lease obligations on leased facilities, against about $392 million of cash. The premium multiple assumes the acquisition-led growth continues; consensus for Q4 2026 is about $2.18 EPS on ~$1.60 billion of revenue, and the five-analyst mean target is about $226.
Which ETFs hold The Ensign Group, Inc. (ENSG)?
If you want ENSG exposure as part of a larger bundle, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.
| ETF | Name | % in ENSG | Expense ratio | |
|---|---|---|---|---|
| SCHA | Schwab U.S. Small-Cap ETF | 0.25% | 0.03% |
Who competes with The Ensign Group, Inc. (ENSG)?
Skilled nursing and post-acute operators
Companies such as PACS Group, National HealthCare Corporation, and the restructured Genesis HealthCare operate overlapping skilled nursing facilities. They compete with Ensign for acquisitions, staff, and referral relationships, though few match its decentralized operating model or acquisition track record.
Senior living and assisted living
Brookdale Senior Living and Sonida Senior Living focus on assisted living and independent living, overlapping with Ensign's senior living segment. These operators compete for older residents and private-pay revenue in the broader continuum of elder care.
Healthcare REITs and real estate owners
Through its Standard Bearer real estate arm, Ensign overlaps with healthcare REITs like Omega Healthcare Investors and CareTrust REIT (a former Ensign spinoff) that own skilled nursing real estate and lease it to operators.
What stocks are similar to The Ensign Group, Inc. (ENSG)?
Other names that sit close to ENSG: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.
How to invest in The Ensign Group, Inc. (ENSG)
There are three common ways to get ENSG exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (SCHA), which spreads the position across many companies. Or build it into a focused thematic portfolio, so ENSG sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where ENSG fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on The Ensign Group, Inc. (ENSG)
Ensign is a rare skilled-nursing operator that keeps compounding revenue and earnings at double-digit rates, and the market prices it accordingly, though the shares have been roughly flat over the past year while the business kept growing and expanded into Florida.
More on The Ensign Group, Inc. (ENSG)
Whether ENSG is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ENSG a buy or a sell?, and where the stock could go from here in the ENSG stock forecast.
For income investors, whether ENSG pays a dividend and how the payout looks is covered in does ENSG pay a dividend? And to weigh ENSG against a peer, read the full side-by-side comparisons: ENSG vs NHC and ENSG vs GEL.
Wondering how ENSG fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about The Ensign Group, Inc.
Ask Walnut's AI anything about ENSG and see how it fits what you own.
FAQ
What does The Ensign Group do?
+
Ensign operates skilled nursing facilities, senior living communities, and rehabilitation and therapy services across the US through a network of independently run local subsidiaries. It also owns much of the underlying real estate through its Standard Bearer arm.
How does Ensign make money?
+
It earns revenue mostly from Medicare, Medicaid, and private insurance reimbursement for short-term rehabilitation and long-term care at its skilled nursing and senior living facilities, plus rental income from the properties it owns.
Is ENSG a growth stock?
+
Ensign has delivered years of double-digit revenue and earnings growth driven by acquisitions and operational improvements, so it is generally viewed as a growth-oriented compounder rather than a slow, mature healthcare stock.
What were Ensign's recent results?
+
In Q3 2026, reported October 27, revenue rose about 14.5% year over year to roughly $1.48 billion and adjusted EPS of $2.03 beat the ~$1.97 consensus, after Q2 revenue of ~$1.44 billion (up ~17%) and adjusted EPS of $1.92. Ensign added 22 operations in the quarter, including its first in Florida, and set its full-year 2026 revenue guidance midpoint at about $5.91 billion. Analyst consensus for 2026 now sits near $7.98 of EPS.
How is ENSG valued?
+
As of November 20, 2026 Ensign had a market cap near $10.4 billion, a trailing P/E around 26x, and a forward P/E near 20x, with the stock around $178. That is a premium to many healthcare-facility peers, a premium earned by its consistent growth.
Who are Ensign's main competitors?
+
Skilled nursing and post-acute peers include PACS Group, National HealthCare, and Genesis HealthCare. In senior living it overlaps with Brookdale and Sonida, and on the real estate side with healthcare REITs like Omega Healthcare and CareTrust REIT.
What are the biggest risks for Ensign?
+
The main risks are cuts or unfavorable changes to Medicare and Medicaid reimbursement, labor shortages and wage inflation, potential federal minimum-staffing mandates, integration risk from constant acquisitions, and a premium valuation that leaves little room for a growth slowdown.
Does Ensign pay a dividend?
+
Ensign pays a small dividend, about $0.26 per share a year, and has a long history of modest annual increases, but the yield is very low (about 0.15% in November 2026) because the company reinvests most of its cash into acquisitions and growth.
How has ENSG stock performed in 2026?
+
As of November 20, 2026, ENSG closed at about $177.93, up roughly 2% year to date and down about 1% over one year, within a 52-week range of roughly $142 to $218. Shares briefly rose to about $188 after the Q3 report before giving the gain back. The five-analyst mean target is about $226. The flat share price contrasts with revenue growing about 15% and five straight quarters of EPS beats. This is descriptive data, not a recommendation.
When does Ensign report Q3 2026 earnings?
+
Ensign reported Q3 2026 on October 27, 2026: revenue of about $1.48 billion and adjusted EPS of $2.03, ahead of the ~$1.97 consensus. The next report, for Q4 2026, typically comes in early February; consensus calls for EPS of about $2.18 on roughly $1.60 billion of revenue, about 20% EPS growth from the prior-year quarter.
Is Ensign expanding into Florida?
+
Yes. In the third quarter of 2026 Ensign acquired 22 new operations, including its first in Florida. Management called Florida a dynamic healthcare market but noted a busy litigation environment and the need to prove clinical results to local payers, and said the Florida and Texas buildings are very challenged and will take time to contribute meaningfully.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with The Ensign Group, Inc.'s investor relations page or your broker before making investment decisions.